The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
112274033 11227403 3 F 20160908 20150630 20160915 PER US-ALEXION-A201502390 ALEXION 0.00 F Y 0.00000 20160915 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
112274033 11227403 1 PS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, QMONTH T3-AD4285B01 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION /month

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
112274033 11227403 1 Haemolytic uraemic syndrome

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
112274033 11227403 Alopecia
112274033 11227403 Back pain
112274033 11227403 Headache
112274033 11227403 Inappropriate schedule of drug administration
112274033 11227403 Lethargy
112274033 11227403 Neck pain

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found